Logo image of PSEC

PROSPECT CAPITAL CORP (PSEC) Stock Fundamental Analysis

NASDAQ:PSEC - Nasdaq - US74348T1025 - Common Stock - Currency: USD

4.44  -0.01 (-0.22%)

After market: 4.46 +0.02 (+0.45%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PSEC. PSEC was compared to 225 industry peers in the Capital Markets industry. There are concerns on the financial health of PSEC while its profitability can be described as average. PSEC has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year PSEC was profitable.
In the past year PSEC had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PSEC reported negative net income in multiple years.
In multiple years PSEC reported negative operating cash flow during the last 5 years.
PSEC Yearly Net Income VS EBIT VS OCF VS FCFPSEC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

The Return On Assets of PSEC (-1.26%) is worse than 81.28% of its industry peers.
The Return On Equity of PSEC (-1.80%) is worse than 79.45% of its industry peers.
PSEC has a Return On Invested Capital (4.14%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for PSEC is below the industry average of 6.82%.
The last Return On Invested Capital (4.14%) for PSEC is above the 3 year average (4.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.26%
ROE -1.8%
ROIC 4.14%
ROA(3y)2.32%
ROA(5y)4.38%
ROE(3y)3.67%
ROE(5y)6.97%
ROIC(3y)4.06%
ROIC(5y)3.98%
PSEC Yearly ROA, ROE, ROICPSEC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

PSEC's Profit Margin has declined in the last couple of years.
The Operating Margin of PSEC (46.92%) is better than 83.11% of its industry peers.
PSEC's Operating Margin has improved in the last couple of years.
PSEC has a better Gross Margin (52.94%) than 61.64% of its industry peers.
PSEC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 46.92%
PM (TTM) N/A
GM 52.94%
OM growth 3Y2.53%
OM growth 5Y1.85%
PM growth 3Y-51.74%
PM growth 5Y-3.58%
GM growth 3Y2.62%
GM growth 5Y1.89%
PSEC Yearly Profit, Operating, Gross MarginsPSEC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

3

2. Health

2.1 Basic Checks

The number of shares outstanding for PSEC has been increased compared to 1 year ago.
Compared to 5 years ago, PSEC has more shares outstanding
The debt/assets ratio for PSEC has been reduced compared to a year ago.
PSEC Yearly Shares OutstandingPSEC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
PSEC Yearly Total Debt VS Total AssetsPSEC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.66, we must say that PSEC is in the distress zone and has some risk of bankruptcy.
PSEC has a worse Altman-Z score (0.66) than 61.64% of its industry peers.
PSEC has a debt to FCF ratio of 3.69. This is a good value and a sign of high solvency as PSEC would need 3.69 years to pay back of all of its debts.
PSEC's Debt to FCF ratio of 3.69 is fine compared to the rest of the industry. PSEC outperforms 69.86% of its industry peers.
PSEC has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PSEC (0.41) is better than 73.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 3.69
Altman-Z 0.66
ROIC/WACCN/A
WACCN/A
PSEC Yearly LT Debt VS Equity VS FCFPSEC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

PSEC has a Current Ratio of 0.59. This is a bad value and indicates that PSEC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.59, PSEC is not doing good in the industry: 71.69% of the companies in the same industry are doing better.
PSEC has a Quick Ratio of 0.59. This is a bad value and indicates that PSEC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.59, PSEC is not doing good in the industry: 71.69% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
PSEC Yearly Current Assets VS Current LiabilitesPSEC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1

3. Growth

3.1 Past

PSEC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.59%.
PSEC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.68% yearly.
Looking at the last year, PSEC shows a decrease in Revenue. The Revenue has decreased by -9.90% in the last year.
Measured over the past years, PSEC shows a small growth in Revenue. The Revenue has been growing by 4.13% on average per year.
EPS 1Y (TTM)-13.59%
EPS 3Y9.44%
EPS 5Y2.68%
EPS Q2Q%-16.67%
Revenue 1Y (TTM)-9.9%
Revenue growth 3Y10.89%
Revenue growth 5Y4.13%
Sales Q2Q%114.85%

3.2 Future

PSEC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -18.23% yearly.
PSEC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -8.02% yearly.
EPS Next Y-41.11%
EPS Next 2Y-25.35%
EPS Next 3Y-18.23%
EPS Next 5YN/A
Revenue Next Year-14.92%
Revenue Next 2Y-11.21%
Revenue Next 3Y-8.02%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PSEC Yearly Revenue VS EstimatesPSEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PSEC Yearly EPS VS EstimatesPSEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.99 indicates a rather cheap valuation of PSEC.
PSEC's Price/Earnings ratio is rather cheap when compared to the industry. PSEC is cheaper than 94.98% of the companies in the same industry.
PSEC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.62.
With a Price/Forward Earnings ratio of 8.21, the valuation of PSEC can be described as very reasonable.
86.76% of the companies in the same industry are more expensive than PSEC, based on the Price/Forward Earnings ratio.
PSEC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 4.99
Fwd PE 8.21
PSEC Price Earnings VS Forward Price EarningsPSEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of PSEC indicates a rather cheap valuation: PSEC is cheaper than 87.21% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.52
EV/EBITDA N/A
PSEC Per share dataPSEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PSEC's earnings are expected to decrease with -18.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.86
EPS Next 2Y-25.35%
EPS Next 3Y-18.23%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.13%, PSEC is a good candidate for dividend investing.
PSEC's Dividend Yield is rather good when compared to the industry average which is at 10.21. PSEC pays more dividend than 81.28% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, PSEC pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.13%

5.2 History

The dividend of PSEC has a limited annual growth rate of 5.35%.
PSEC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)5.35%
Div Incr Years0
Div Non Decr Years0
PSEC Yearly Dividends per sharePSEC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

PSEC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-404.93%
EPS Next 2Y-25.35%
EPS Next 3Y-18.23%
PSEC Yearly Income VS Free CF VS DividendPSEC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

PROSPECT CAPITAL CORP

NASDAQ:PSEC (2/21/2025, 8:00:01 PM)

After market: 4.46 +0.02 (+0.45%)

4.44

-0.01 (-0.22%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-10 2025-02-10/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners10.79%
Inst Owner Change-80.28%
Ins Owners18.55%
Ins Owner Change11.02%
Market Cap1.97B
Analysts40
Price Target4.08 (-8.11%)
Short Float %4.95%
Short Ratio4.99
Dividend
Industry RankSector Rank
Dividend Yield 12.13%
Yearly Dividend0.87
Dividend Growth(5Y)5.35%
DP-404.93%
Div Incr Years0
Div Non Decr Years0
Ex-Date04-28 2025-04-28 (0.045)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.58%
Min EPS beat(2)21.11%
Max EPS beat(2)40.06%
EPS beat(4)4
Avg EPS beat(4)27.52%
Min EPS beat(4)12.75%
Max EPS beat(4)40.06%
EPS beat(8)8
Avg EPS beat(8)20.9%
EPS beat(12)12
Avg EPS beat(12)19.72%
EPS beat(16)16
Avg EPS beat(16)18.35%
Revenue beat(2)0
Avg Revenue beat(2)-5.07%
Min Revenue beat(2)-6.01%
Max Revenue beat(2)-4.14%
Revenue beat(4)1
Avg Revenue beat(4)-4.07%
Min Revenue beat(4)-7.33%
Max Revenue beat(4)1.21%
Revenue beat(8)3
Avg Revenue beat(8)-9.72%
Revenue beat(12)6
Avg Revenue beat(12)-5.57%
Revenue beat(16)9
Avg Revenue beat(16)-3.76%
PT rev (1m)0%
PT rev (3m)-11.11%
EPS NQ rev (1m)7.69%
EPS NQ rev (3m)-12.5%
EPS NY rev (1m)3.7%
EPS NY rev (3m)-8.2%
Revenue NQ rev (1m)-5.6%
Revenue NQ rev (3m)-13.4%
Revenue NY rev (1m)-3.28%
Revenue NY rev (3m)-7.07%
Valuation
Industry RankSector Rank
PE 4.99
Fwd PE 8.21
P/S 2.47
P/FCF 3.52
P/OCF 3.52
P/B 0.39
P/tB 0.39
EV/EBITDA N/A
EPS(TTM)0.89
EY20.05%
EPS(NY)0.54
Fwd EY12.18%
FCF(TTM)1.26
FCFY28.37%
OCF(TTM)1.26
OCFY28.37%
SpS1.8
BVpS11.45
TBVpS11.45
PEG (NY)N/A
PEG (5Y)1.86
Profitability
Industry RankSector Rank
ROA -1.26%
ROE -1.8%
ROCE 5.24%
ROIC 4.14%
ROICexc 4.18%
ROICexgc 4.18%
OM 46.92%
PM (TTM) N/A
GM 52.94%
FCFM 70.04%
ROA(3y)2.32%
ROA(5y)4.38%
ROE(3y)3.67%
ROE(5y)6.97%
ROIC(3y)4.06%
ROIC(5y)3.98%
ROICexc(3y)4.1%
ROICexc(5y)4.01%
ROICexgc(3y)4.1%
ROICexgc(5y)4.01%
ROCE(3y)5.14%
ROCE(5y)5.03%
ROICexcg growth 3Y5.53%
ROICexcg growth 5Y-0.41%
ROICexc growth 3Y5.53%
ROICexc growth 5Y-0.41%
OM growth 3Y2.53%
OM growth 5Y1.85%
PM growth 3Y-51.74%
PM growth 5Y-3.58%
GM growth 3Y2.62%
GM growth 5Y1.89%
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 3.69
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.56
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z 0.66
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.59%
EPS 3Y9.44%
EPS 5Y2.68%
EPS Q2Q%-16.67%
EPS Next Y-41.11%
EPS Next 2Y-25.35%
EPS Next 3Y-18.23%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.9%
Revenue growth 3Y10.89%
Revenue growth 5Y4.13%
Sales Q2Q%114.85%
Revenue Next Year-14.92%
Revenue Next 2Y-11.21%
Revenue Next 3Y-8.02%
Revenue Next 5YN/A
EBIT growth 1Y-14.59%
EBIT growth 3Y13.69%
EBIT growth 5Y6.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y180.7%
FCF growth 3Y108.25%
FCF growth 5Y4.58%
OCF growth 1Y180.7%
OCF growth 3Y108.25%
OCF growth 5Y4.58%